Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes

Podobne zapisy

• The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
  od: Deane, Adam M, i wsp.
  Wydane: (2009)
• Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill
  od: Deane, A, i wsp.
  Wydane: (2009)
• The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
  od: Lee, Michael Y., i wsp.
  Wydane: (2013)
• Comparative effects on glucose absorption of intragastric and post-pyloric nutrient delivery in the critically ill
  od: Di Bartolomeo, Anna E, i wsp.
  Wydane: (2012)
• Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
  od: Chapman, M, i wsp.
  Wydane: (2011)